Why the study?
Does a standardized clinical pathway reduce 30-day mortality in hip fracture patients?
Does a standardized clinical pathway reduce 30-day mortality in hip fracture patients?
A standardized clinical pathway for hip fracture patients is associated with reduced 30-day mortality.
May support standardized hip fracture pathways for mortality; leaves open confirmation in RCTs and effects on quality of life.
A standardized clinical pathway for hip fracture patients was associated with reduced 30-day mortality, but no clinically important difference in quality of life compared to a non-standardized clinical pathway.
No takes yet. Share an insight, caveat, or question.
Garre-Fivelsdal et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: